<div id="readability-page-1"><div><p><span>Dillione Janet Director of CorMedix Inc [CRMD] filed a Form 4 on November 26, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>11/24/25</span></td><td><span>Exercise(1)</span></td><td><span>26,343</span></td><td><span>$3.64</span></td><td><span>$95,949</span></td></tr><tr><td><span>11/24/25</span></td><td><span>Sale</span></td><td><span>26,343</span></td><td><span>$9.93</span></td><td><span>$261,586</span></td></tr></tbody></table></div><p><span>Ending Holdings: 48,473 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>8,000 shares exercised 2.2 years before expiration date.</span></td></tr><tr><td><span> </span></td><td><span>7,790 shares exercised 6.2 years before expiration date.</span></td></tr><tr><td><span> </span></td><td><span>5,677 shares exercised 8.3 years before expiration date.</span></td></tr><tr><td><span> </span></td><td><span>4,876 shares exercised 7.1 years before expiration date.</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

CRMD

<p>Janet Dillione, Director of CorMedix Inc, filed a Form 4 with the SEC on November 26, 2025, disclosing the sale of 26,343 shares at $9.93 each, totaling $261,586. The shares were exercised at $3.64 each. Ending holdings are 48,473 shares. The Washington Service offers insider trading analysis and data services.</p>

Dir Dillione Sells 26,343 ($261.6K) Of CorMedix Inc [CRMD]